Navigation Links
New Jersey Hospital to Pay $3.85 Million to Resolve Allegations of Inflating Charges to Obtain Higher Medicare Reimbursement
Date:9/24/2008

WASHINGTON, Sept. 24 /PRNewswire-USNewswire/ -- Cooper University Hospital in Camden, N.J., has agreed to pay the United States $3.85 million, plus interest, to settle allegations that it defrauded Medicare, the Justice Department announced today.

The settlement resolves allegations that the hospital improperly increased charges to Medicare patients to obtain enhanced reimbursement from the federal health care program. In addition to its standard payment system, Medicare pays supplemental reimbursement, called outlier payments, to hospitals in cases where the cost of care is unusually high. Congress had enacted the supplemental payment system to provide the incentive to hospitals to treat such patients.

The Justice Department alleged that, between January 2001 and August 2003, Cooper improperly inflated charges for inpatient and outpatient care to make its costs for providing such care appear greater than they actually were, and thereby obtain outlier payments from Medicare that it was not entitled to receive.

"Today's settlement demonstrates the commitment by the Justice Department to combating practices by which hospitals knowingly overcharge the federal Medicare program," said Assistant Attorney General Gregory G. Katsas, head of the Department's Civil Division.

"This office remains determined to ensure the integrity of the Medicare system for the citizens of New Jersey," said Christopher J. Christie, U.S. Attorney for the District of New Jersey.

The civil settlement agreement resolves allegations against Cooper originally brought in a suit by Anthony Kite. Under the False Claims Act, private citizens may bring lawsuits on behalf of the federal government. Under the settlement, Mr. Kite will receive $654,500.

The settlement with Cooper was the result of a coordinated effort among the Justice Department's Civil Division, Commercial Litigation Branch; the U.S. Attorney's Office for the District of New Jersey, Affirma
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Video: Circulatory Care of New Jersey
2. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
3. First New York/New Jersey Health Care Report Card Released
4. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
5. New Jersey Nets Shoot Down Staph with High-Tech Defense
6. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
7. New Jersey Entrepreneur Turns a Page for Four National Charities
8. FDA Inspects Hoviones Technology Transfer Center in New Jersey
9. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
10. Distinctive Art Auction Supports American Red Cross of Central New Jersey
11. Keisha Orr of Edgewater Park, New Jersey is Named Philadelphias 2007 Local Loser
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... of invasive lionfish causing fish poisoning may be unfounded. ... derbies and targeted fisheries may remain the best way ... to know for sure whether a lionfish is toxic: ... lionfish were first reported off the coast of Florida ... number ever since. They,re now found in marine habitats ...
(Date:7/31/2014)... Bedford Commons OB-GYN partnered with ... ReEnergizers to do what Christina Haag, the practice ... the community all while still offering the greatest service ... to women’s health needs for every stage of their ... care ( Gynecology ), worked diligently with their marketing ...
(Date:7/31/2014)... 31, 2014 Today, Good Neighbor ... enhance patient care by kicking off another year ... The first of many education sessions and initiatives ... 2014, Good Neighbor Pharmacy and AmerisourceBergen’s annual conference. ... Services (CMS) Star Measures were a highlight and ...
(Date:7/31/2014)... 2014 Ticket Down is a ... Dick’s Sporting Goods Park in suburban Denver on Tuesday, ... soccer team has found a second home competing on American ... time playing international friendly games and will look to have ... Goods Park in Commerce City, Colorado. The match will be ...
(Date:7/31/2014)... HealthDay Reporter , THURSDAY, July 31, ... food, TVs or cigarettes, but people of ancient times commonly ... speculates on some reasons why. Using CT scans of ... the American Southwest, researchers have found evidence of widespread atherosclerosis ... build up, eventually leading to heart attack or stroke. ...
Breaking Medicine News(10 mins):Health News:Invasive lionfish likely safe to eat after all 2Health News:Invasive lionfish likely safe to eat after all 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 4Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 2Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 3
... drug prolonged progression-free survival, study finds , , SATURDAY, ... Avastin to chemotherapy lengthened progression-free survival in women ... Previous studies have found that adding Avastin (bevacizumab) ... with advanced breast cancer actually doubled progression-free survival. ...
... Anti-angiogenesis drug prolonged progression-free survival, study finds , , ... drug Avastin to chemotherapy lengthened progression-free survival in ... , Previous studies have found that adding Avastin ... women with advanced breast cancer actually doubled progression-free ...
... Phase II studies demonstrated potential for pazopanib as a single,agent treatment for ... -- In patients with stage I-III non-small cell lung cancer, 86 ... experienced a reduction in tumor volume ... overall response rate of 35 percent. The ...
... AIDS Walk, Run and Wellness Festival with ... at 9:30 a.m., Walk at 10 a.m., BOSTON, May 31 ... weekend, took a break from her rehearsal,on Friday night to meet ... Walk Boston., (Photo: http://www.newscom.com/cgi-bin/prnh/20080531/CLSA004 ), The 23rd ...
... , A study by Indiana University researchers found ... elderly study participants and their postural stability -- or ... with recent findings by other researchers involving the brain ... probe cognitive function effective at identifying people with poorer ...
... manufacturing, unreliable delivery of the drug , , FRIDAY, May ... drug rotigotine help relieve restless legs syndrome (RLS), according ... -- which stimulate the body,s dopamine system -- are ... rotigotine is already used to treat Parkinson,s disease. This ...
Cached Medicine News:Health News:Avastin Added to Chemo Helps Women With Advanced Breast Cancer 2Health News:Avastin Added to Chemo Helps Women With Advanced Breast Cancer 3Health News:Avastin Added to Chemo Helps Women With Advanced Cancer 2Health News:Avastin Added to Chemo Helps Women With Advanced Cancer 3Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 2Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 3Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 4Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 5Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 6Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 7Health News:NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS 8Health News:Sunday's AIDS Walk Boston at the Esplanade Gets Tribute from Cyndi Lauper at True Colors Concert Tour Launch Rehearsal 2Health News:Indiana University research at the American College of Sports Medicine annual conference 2Health News:Indiana University research at the American College of Sports Medicine annual conference 3Health News:Indiana University research at the American College of Sports Medicine annual conference 4Health News:Indiana University research at the American College of Sports Medicine annual conference 5Health News:Indiana University research at the American College of Sports Medicine annual conference 6Health News:Indiana University research at the American College of Sports Medicine annual conference 7Health News:Rotigotine Skin Patch May Ease Restless Legs Symptoms 2
(Date:7/31/2014)... Mass. , July 31, 2014  A ... members—who make decisions about which therapies are included ... formulary placement, according to a new Manhattan Research ... 2014 . The study finds that P&T committee ... pharmacy benefits managers (PBMs) have set a high ...
(Date:7/31/2014)... , July 31, 2014 Lazarus Effect, a ... interventional devices to facilitate removal of blood clots, announced ... the financing will support EU commercialization of several approved ... the Lazarus ReCover™ and Lazarus Cover™ in ... reflects investor confidence in the value of our novel, ...
(Date:7/31/2014)... 31, 2014 For its innovative modular Biomedical ... , Art,s-Way Scientific has earned a Modular Building Institute ... in over 30 categories, MBI,s contest is the commercial ... include building manufacturers, dealers, and product and service providers. ... the capability of our team," said Dan Palmer ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Lazarus Effect Closes $5 Million Financing 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) today announced that ... viewing. LINK: www.retailinvestorconferences.com > Click the ... Pharmaceuticals, presentation will be available for 90 days. Investors ... for the next three weeks. About ...
... June 6, 2011 Express Scripts, Inc. (Nasdaq: ... Blair 2011 Growth Stock Conference on June 16, 2011 at ... Hotel in Chicago. This presentation will also ... the investor relations section of Express Scripts web site at ...
Cached Medicine Technology:Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: